A method for selection of beam angles robust to intra-fractional motion in proton therapy of lung cancer

References

• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10–29.
   PubMed Web of Science ®Google Scholar
• Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095–128.
   PubMed Web of Science ®Google Scholar
• Binder D, Hegenbarth K. Emerging options for the management of non-small cell lung cancer. Clin Med Insights Oncol 2013;7:221–34.
   PubMedGoogle Scholar
• Allen AM, Pawlicki T, Dong L, Fourkal E, Buyyounouski M, Cengel K, et al. An evidence based review of proton beam therapy: The report of ASTRO's emerging technology committee. Radiother Oncol 2012;103:8–11.
   PubMed Web of Science ®Google Scholar
• Colaco RJ, Huh S, Nichols RC, Morris CG, D’Agostino H, Flampouri S, et al. Dosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancer. Acta Oncol 2013; 52:506–13.
   PubMed Web of Science ®Google Scholar
• De Ruysscher D, Chang JY. Clinical controversies: Proton therapy for thoracic tumors. Semin Radiat Oncol 2013; 23:115–9.
   PubMed Web of Science ®Google Scholar
• Pijls-Johannesma M, Grutters JPC, Verhaegen F, Lambin P, De Ruysscher D. Do we have enough evidence to implement particle therapy as standard treatment in lung cancer?A systematic literature review. Oncologist 2010;15:93–103.
   Google Scholar
• Vogelius IR, Westerly DC, Aznar MC, Cannon GM, Korreman SS, Mackie TR, et al. Estimated radiation pneumonitis risk after photon versus proton therapy alone or combined with chemotherapy for lung cancer. Acta Oncol 2011;50:772–6.
   PubMed Web of Science ®Google Scholar
• La Tessa C, Berger T, Kaderka R, Schardt D, Körner C, Ramm U, et al. Out-of-field dose studies with an anthropomorphic phantom: Comparison of x-rays and particle therapy treatments. Radiother Oncol 2012;105:133–8.
   PubMed Web of Science ®Google Scholar
• De Ruysscher D, Mark Lodge M, Jones B, Brada M, Munro A, Jefferson T, et al. Charged particles in radiotherapy: A 5-year update of a systematic review. Radiother Oncol 2012;103:5–7.
   PubMed Web of Science ®Google Scholar
• Stuschke M, Kaiser A, Pöttgen C, Lübcke W, Farr J. Potentials of robust intensity modulated scanning proton plans for locally advanced lung cancer in comparison to intensity modulated photon plans. Radiother Oncol 2012;104:45–51.
   PubMed Web of Science ®Google Scholar
• Chang J, Cox J. Improving radiation conformality in the treatment of non-small-cell lung cancer. Semin Radiat Oncol 2010;20:171–7.
   PubMed Web of Science ®Google Scholar
• Liu HH, Balter P, Tutt T, Choi B, Zhang J, Wang C, et al. Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer. Int J Radiat Oncol Biol Phys 2007;68:531–40.
   PubMed Web of Science ®Google Scholar
• Sonke JJ, Lebesque J, van Herk M. Variability of four- dimensional computed tomography patient models. Int J Radiat Oncol Biol Phys 2008;70:590–8.
   PubMed Web of Science ®Google Scholar
• Britton KR, Starkschall G, Tucker SL, Pan T, Nelson C, Chang JY, et al. Assessment of gross tumor volume regression and motion changes during radiotherapy for non-small-cell lung cancer as measured by four-dimensional computed tomography. Int J Radiat Oncol Biol Phys 2007;68:1036–46.
   PubMed Web of Science ®Google Scholar
• Von Siebenthal M, Székely G, Gamper U, Boesiger P, Lomax A, Cattin P. 4D MR imaging of respiratory organ motion and its variability. Phys Med Biol 2007;52:1547–64.
   PubMed Web of Science ®Google Scholar
• Bert C, Durante M. Motion in radiotherapy: Particle therapy. Phys Med Biol 2011;56:R113–44.
   PubMed Web of Science ®Google Scholar
• Liao Z, Lin SH, Cox JD. Status of particle therapy for lung cancer. Acta Oncol 2011;50:745–56.
   PubMed Web of Science ®Google Scholar
• Graeff C, Durante M, Bert C. Motion mitigation in intensity modulated particle therapy by internal target volumes covering range changes. Med Phys 2012;39:6004–13.
   PubMed Web of Science ®Google Scholar
• Bortfeld T, Jiang SB, Rietzel E. Effects of motion on the total dose distribution. Semin Radiat Oncol 2004;14:41–51.
   PubMed Web of Science ®Google Scholar
• Hopfgartner J, Stock M, Knäusl B, Georg D. Robustness of IMPT treatment plans with respect to inter-fractional set-up uncertainties: Impact of various beam arrangements for cranial targets. Acta Oncol 2013;52:570–9.
   PubMed Web of Science ®Google Scholar
• Thörnqvist S, Muren LP, Bentzen L, Hysing LB, Høyer M, Grau C, et al. Degradation of target coverage due to inter-fraction motion during intensity-modulated proton therapy of prostate and elective targets. Acta Oncol 2013;52:521–7.
   PubMed Web of Science ®Google Scholar
• Wang N, Patyal B, Ghebremedhin A, Bush D. Evaluation and comparison of new 4DCT based strategies for proton treatment planning for lung tumors. Radiat Oncol 2013;8:73.
   PubMed Web of Science ®Google Scholar
• Knopf AC, Boye D, Lomax A, Mori S. Adequate margin definition for scanned particle therapy in the incidence of intrafractional motion. Phys Med Biol 2013;58:6079–94.
   PubMed Web of Science ®Google Scholar
• Mori S, Dong L, Starkschall G, Mohan R, Chen GTY. A serial 4DCT study to quantify range variations in charged particle radiotherapy of thoracic cancers. J Radiat Res 2014;55:309–19.
   PubMed Web of Science ®Google Scholar
• Santiago A, Jelen U, Ammazzalorso F, Engenhart-Cabillic R, Fritz P, Mühlnickel W, et al. Reproducibility of target coverage in stereotactic spot scanning proton lung irradiation under high frequency jet ventilation. Radiother Oncol 2013;109:45–50.
   PubMed Web of Science ®Google Scholar
• Vandemeulebroucke J, Rit S, Kybic J, Clarysse P, Sarrut D. Spatiotemporal motion estimation for respiratory-correlated imaging of the lungs. Med Phys 2011;38:166.
   PubMed Web of Science ®Google Scholar
• Krämer M, Scholz M. Treatment planning for heavy-ion radiotherapy: Calculation and optimization of biologically effective dose. Phys Med Biol 2000;45:3319–30.
   PubMed Web of Science ®Google Scholar
• Krämer M, Jäkel O, Haberer T, Kraft G, Schardt D, Weber U. Treatment planning for scanned ion beams. Radiother Oncol 2004;73(Suppl 2):S80–5.
   PubMed Web of Science ®Google Scholar
• Krämer M, Durante M. Ion beam transport calculations and treatment plans in particle therapy. Eur Phys J D 2010;60: 195–202.
   Web of Science ®Google Scholar
• Toftegaard J, Petersen JB, Bassler N. PyTRiP – a toolbox and GUI for the proton/ion therapy planning system TRiP. J Phys Conf Ser 2014;489:012045.
   Google Scholar